Ch
EN
Home
About Us
Company Profile
Management Team
Company Culture
Enterprise Honor
Investor Relations
News
Industry News
Policies and Regulations
Products
Product List
R&D
Technology
Professionals
Clinical Findings
Literature Downloads
FAQ
Patients
Join us
TEAM
Contact Us
Home
>
News
>
Industry News
News
Industry News
Policies and Regulations
Industry News
2017 BRICs cooperation meeting on drug supervision was held in Zhengzhou
发布时间:2017-07-21
On 13-14 July, the BRICs Cooperation meeting on drug supervision was held in Zhengzhou, capital of Henan province, in 2017.CFDA’s Vice Minister Wu Zhen attended the meeting and delivered a speech,representatives of the BRICs drug regulatory bodies and the industry attended the meeting.At the meeting, the latest drug regulatory regulations and policies were exchanged,and the direction of possible cooperation in drug registration and supervision was discussed.
Since 2015, the BRICs meeting individual drug regulatory cooperation, all Member States in drug evaluation and approval, supervision and inspection, pharmacovigilance, supply chain security began to try to establish a normal cooperative mechanism.
Wu Zhen said that in June this year, the CFDA as an official member of ICH, means that the drug regulatory authorities, Chinese pharmaceutical industry and research institutions will be gradually transformed and implement international technical standards and guidelines, participate in the formulation of international rules, to promote international innovative drugs to enter the Chinese market and promote Chinese pharmaceutical products to the world.
(Source: CFDA)
上一篇:
The 8th China International Medical Device Regulatory Conference held in Hangzhou
下一篇:
DNA methylation could identify at least 4 common cancers: study